News|Articles|July 9, 2024
Optimizing the cell and gene therapy patient journey through integrated CRO/CDMO partnership
Author(s)Patheon
Related Content
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
4
CPHI Milan Names 2026 Pharma Awards Finalists
5